Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-24 @ 2:56 PM
NCT ID:
NCT05294159
Eligibility Criteria:
Inclusion Criteria:
* ≥ 18 years of age
* Documented HIV-1 infection
* Virologically suppressed (HIV-1 RNA \<50 copies/ml) on a stable antiretroviral regimen
* Able and willing to complete informed consent prior to inclusion
* No hepatitis B
* In accordance with EU license and NICE guidance
Exclusion Criteria:
* Based on contraindication for CAB LA, RPV LA, in accordance with EU license and NICE guidance
* Prior virologic failure on substances of NNRTI or INI class
* Resistance mutations to any substance of the NNRTI or INI class
* Prior exposure to CAB + RPV LA
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05294159
Study Brief:
Protocol Section:
NCT05294159